Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Diamonds and Dogs

12/30/14

NeuroDerm Ltd. (NDRM)

NeuroDerm more than hit the daily double today, up 162.46% to $16.22. The pharmaceutical company saw its shares explode after encouraging news from their Parkinson's drug. NeuroDerm announced continuous, subcutaneous dosage of two of its proprietary liquid levodopa/carbidopa (LD/CD) product candidates, ND0612H and ND0612L, resulted in clinically significant plasma levadopa levels. The data indicates that the high dose version, ND0612H, meant for patients with severe Parkinson's disease, could be an effective therapy alternative to current treatments that require surgery. Shares of the company climbed over $10 per share today and hit a new 52-week high of $16.73 intraday.

Civeo Corporation (CVEO)

Civeo Corporation is getting hit hard today, down 52.00% to $3.97. The Canadian oil sands company watched its shares fall after oil prices continued their decline, which is affecting Civeo's outlook. The oil and gas field services company now expects revenue of $160 million to $175 million, below the $196.5 million analysts were expecting. Furthermore, Civeo also sees 2015 revenue of $540 million to $600 million vs. the $725 million that analysts forecast. Due to the lower expectations; the company suspended its dividend, and analysts from Susquehanna lowered their price target from $10 to $6. Shares of Civeo fell over $4.30 today to a new 52-week low of $3.88.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.